NCT03587454

Brief Summary

Telemedicine allows screening of subjects with limited access to eye care. Failure of screenees to come for full examination was identified as a serious problem. Teleglaucoma should allow a single physician access to screenees in real time. The investigators aim to test the technical feasibility of developing a system for teleglaucoma that will allow a physician real time access to patient information and images and compare it to traditional physical presence evaluation in glaucoma clinics. This system can be applied during telemedicine for glaucoma and other vision threatening diseases.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

May 21, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 16, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

August 23, 2021

Status Verified

August 1, 2021

Enrollment Period

3.1 years

First QC Date

May 21, 2018

Last Update Submit

August 16, 2021

Conditions

Keywords

teleglaucomateleophthalmology

Outcome Measures

Primary Outcomes (1)

  • Comparison of diagnosis and management in Teleglaucoma and conventional care

    Qualitative categorical outcome: Glaucoma Diagnosis, Management and follow up are clinical determinations by the investigator that are based on the overall clinical evaluation of the subject Diagnosis: A. no glaucoma B. confirmed glaucoma Management: A. maintain current therapy, B. advance therapy (additional glaucoma medication or surgical glaucoma intervention), C. no therapy needed Follow up: A. urgent (less than 4 weeks from time of evaluation) B. routine (more than 4 weeks from time of evaluation)

    24 months

Secondary Outcomes (4)

  • Assessment of diagnostic tools during teleglaucoma: Visual acuity

    12 months

  • Assessment of diagnostic tools during teleglaucoma: Tonometry

    12 months

  • Assessment of diagnostic tools during tele glaucoma: Optic nerve

    12 months

  • Assessment of diagnostic tools during tele glaucoma: Optical Coherence Tomography

    12 months

Study Arms (1)

Tele-Glaucoma arm

EXPERIMENTAL

Subjects enrolled in tele-glaucoma arm for remote assessment

Diagnostic Test: Teleglaucoma

Interventions

TeleglaucomaDIAGNOSTIC_TEST

Subjects are evaluated through a teleglaucoma protocol then by physical presence in a glaucoma clinic

Also known as: teleophthalmology
Tele-Glaucoma arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with glaucoma or who are glaucoma suspects

You may not qualify if:

  • Physical limitations precluding image acquisition like the inability to position for imaging or the inability to acquire images/testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Chandrasekaran S, Kass W, Thangamathesvaran L, Mendez N, Khouri P, Szirth BC, Khouri AS. Tele-glaucoma versus clinical evaluation: The New Jersey Health Foundation Prospective Clinical Study. J Telemed Telecare. 2020 Oct;26(9):536-544. doi: 10.1177/1357633X19845273. Epub 2019 May 28.

    PMID: 31138016BACKGROUND

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Albert S Khouri, MD

    Rutgers University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking Details
Investigators in teleglaucoma and conventional glaucoma clinics are masked to one another
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Model Details: Prospective sequential enrolment in teleglaucoma then conventional glaucoma clinical care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 21, 2018

First Posted

July 16, 2018

Study Start

August 1, 2016

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

August 23, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share